INSM Maintains Overweight Rating -- Price Target Lowered to $207

gurufocus.com · 2026-09-30

Insmed (INSM) Analyst Rating Update On September 30, 2026, Barclays maintained an Overweight rating for Insmed (INSM). The price target for the company has b

Read the full story at gurufocus.com →